Checkpoint inhibitors: 'raising the bar' also in brain metastases from non-small-cell lung cancer?

Immunotherapy
Sabrina RossiArmando Santoro

Abstract

Despite efforts, brain metastases (BM) remain a critical issue in the management of patients affected by non-small-cell lung cancer (NSCLC). To date, radiotherapy is still considered the gold standard treatment; on the other hand, systemic chemotherapeutical agents are not so often an effective therapy for BM, whereas targeted agents in oncogene-addicted disease have shown a good activity also on BM. Anti-programmed death-1/programmed death ligand-1 agents represent a new valid therapeutic strategy for NSCLC as well as for several tumor types, but their efficacy on patients with BM is still unclear mainly due to the strict selection criteria adopted in clinical trials. The aim of the present article is to discuss the potential activity of checkpoint inhibitors in patients with BM from NSCLC.

References

Mar 31, 1999·International Journal of Radiation Oncology, Biology, Physics·F J LagerwaardP I Schmitz
Apr 2, 2002·Journal of Immunotherapy·Lisa M GuirguisDouglas J Schwartzentruber
Jul 24, 2003·Nature Reviews. Immunology·Richard M RansohoffGrahame Kidd
May 12, 2006·Neurological Research·Georgette L SuidanAaron J Johnson
Dec 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robert M PrinsAntoni Ribas
May 5, 2010·The Journal of Clinical Investigation·Emma H WilsonChristopher A Hunter
Mar 15, 2011·Journal of Neuro-oncology·Marshall W PitzJaishri O Blakeley
Feb 9, 2012·Clinical & Developmental Immunology·Theodore S JohnsonBernard L Maria
Oct 18, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Leslie L MuldoonEdward A Neuwelt
Mar 7, 2013·International Journal of Radiation Oncology, Biology, Physics·Jing ZengMichael Lim
Oct 31, 2014·Neuro-oncology·Anna Sophie BerghoffWolfgang Wick
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Jul 10, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Masaki ShimojiTetsuya Mitsudomi
Aug 31, 2016·OncoTargets and Therapy·Xin WangJinming Yu
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Feb 6, 2017·Translational Lung Cancer Research·Lorenza Landi, Federico Cappuzzo
Apr 9, 2017·Journal of Hematology & Oncology·Song XueJinming Yu

❮ Previous
Next ❯

Citations

Sep 11, 2018·Expert Review of Anticancer Therapy·Paweł KrawczykKamila Wojas-Krawczyk

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Related Papers

Future Oncology
Anna S Berghoff, Matthias Preusser
European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Fabrice Barlesi
The Journal of the Royal College of Physicians of Edinburgh
K I Rasul, A M Al-Khater
© 2022 Meta ULC. All rights reserved